The Multiple Myeloma and Transplant Program at St. Vincent's Comprehensive Cancer Center is one of the leading clinical programs for the diagnosis and treatment of multiple myeloma.

• Cancer researchers at Manhattan-based St. Vincent's Comprehensive Cancer Center discover genes that can determine how patients respond to pre-leukemia drug.
• Myeloma Physicians at St. Vincent's Chair and Participate in a Multiple Myeloma Research Foundation Symposium
• Specialist in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Brings Subspecialty to SVCCC
• Tayyaba Bashir, MD, Joins Medical Oncology Staff